Form 8-K - Current report:
SEC Accession No. 0000950123-10-023476
Filing Date
2010-03-11
Accepted
2010-03-11 14:12:51
Documents
11
Period of Report
2010-03-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OXIGENE, INC. b80060e8vk.htm 8-K 26984
2 EX-4.1 b80060exv4w1.htm EX-4.1 150182
3 EX-4.2 b80060exv4w2.htm EX-4.2 105209
4 EX-4.3 b80060exv4w3.htm EX-4.3 115261
5 EX-4.4 b80060exv4w4.htm EX-4.4 105547
6 EX-4.5 b80060exv4w5.htm EX-4.5 91397
7 EX-4.6 b80060exv4w6.htm EX-4.6 7912
8 EX-10.1 b80060exv10w1.htm EX-10.1 234610
9 EX-10.2 b80060exv10w2.htm EX-10.2 21440
10 EX-99.1 b80060exv99w1.htm EX-99.1 6235
11 GRAPHIC b80060b8006001.gif GRAPHIC 4882
  Complete submission text file 0000950123-10-023476.txt   873239
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

EIN.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 10673481
SIC: 2836 Biological Products, (No Diagnostic Substances)